| Good neurological outcome | Survival to discharge | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Outcome, n (%) | Crude OR (95% CI) | p Value | Adjusted ORa (95% CI) | p Value | Outcome, n (%) | Crude OR (95% CI) | p Value | Adjusted ORa (95% CI) | p Value | |
Two categorizations | ||||||||||
 Age < 50 years | ||||||||||
  Male | 92 (48.2) | 2.28 (1.38–3.78) | 0.001 | 1.52 (0.77–2.98) | 0.226 | 140 (73.3) | 1.77 (1.07–2.93) | 0.026 | 1.14 (0.62–2.11) | 0.667 |
  Female | 31 (29.0) |  |  |  |  | 65 (60.7) |  |  |  |  |
 Age ≥ 50 years | ||||||||||
  Male | 102 (22.2) | 1.77 (1.09–2.88) | 0.020 | 1.29 (0.72–2.33) | 0.389 | 275 (59.9) | 1.91 (1.34–2.72) | <0.001 | 1.78 (1.21–2.63) | 0.004 |
  Female | 24 (13.9) |  |  |  |  | 76 (43.9) |  |  |  |  |
Five categorizations | ||||||||||
 Age < 40 years | ||||||||||
  Male | 48 (53.9) | 2.81 (1.35–5.85) | 0.006 | 1.34 (0.47–3.84) | 0.584 | 62 (69.7) | 1.36 (0.66–2.82) | 0.402 | 0.79 (0.31–2.00) | 0.620 |
  Female | 15 (29.4) |  |  |  |  | 32 (62.7) |  |  |  |  |
 Age 40–49 years | ||||||||||
  Male | 44 (43.1) | 1.90 (0.94–3.82) | 0.073 | 1.63 (0.65–4.09) | 0.297 | 78 (76.5) | 2.27 (1.12–4.57) | 0.022 | 1.48 (0.63–3.43) | 0.368 |
  Female | 16 (28.6) |  |  |  |  | 33 (58.9) |  |  |  |  |
 Age 50–59 years | ||||||||||
  Male | 57 (34.3) | 2.54 (1.06–6.09) | 0.037 | 2.31 (0.81–6.63) | 0.119 | 118 (71.1) | 2.58 (1.28–5.19) | 0.008 | 2.62 (1.21–5.69) | 0.015 |
  Female | 7 (10.9) |  |  |  |  | 20 (48.8) |  |  |  |  |
 Age 60–69 years | ||||||||||
  Male | 34 (24.3) | 2.19 (0.86–5.61) | 0.102 | 1.25 (0.41–3.81) | 0.693 | 87 (62.1) | 2.03 (1.04–3.97) | 0.038 | 2.02 (0.95–4.28) | 0.068 |
  Female | 6 (12.8) |  |  |  |  | 21 (44.7) |  |  |  |  |
 Age ≥ 70 years | ||||||||||
  Male | 11 (7.2) | 0.52 (0.22–1.26) | 0.147 | 0.56 (0.19–1.63) | 0.289 | 70 (45.8) | 1.21 (0.71–2.06) | 0.496 | 1.40 (0.79–2.51) | 0.251 |
  Female | 11 (12.9) |  |  |  |  | 35 (41.2) |  |  |  |  |